ArticleJournal of hepatocellular carcinoma2025

Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus.

Xiaowei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.